ASCO 2026 Abstracts

2026 ASCO Annual Meeting 

Here is the lineup of posters we are presenting at ASCO. Visit us at booth 17146 to discuss in further detail or learn more about our testing.  

Defining APOBEC-like signature in diffuse large B-cell lymphoma and demonstration of distinct transcriptomic profile. 

Presenter: Adam Albitar, MD 

Date: Jun 1, 2026 

Abstract: 7075 

FROM: Poster Session 

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia 

Dominant chromosomal abnormalities in breast cancer metastasis to CNS as compared with systemic metastasis demonstrated by liquid biopsy. 

Presenter:  To Be Determined 

Date: Jun 1, 2026 

Abstract: 1035 

FROM: Poster Session 

Breast Cancer—Metastatic 

Comprehensive profiling and clinical utility of CSF-derived cell-free DNA/RNA for evaluation of solid and hematologic malignancies affecting the central nervous system. 

Presenter: To Be Determined 

Date: May 30, 2026 

Abstract: 3066 

FROM: Poster Session 

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology 

Distinction of FLT3-ITD transcriptomic signature from FLT3-TKD and the frequency of this signature in acute myeloid leukemia without FLT3 mutation. 

Presenter: To Be Determined 

Date: Jun 1, 2026 

Abstract: 6538 

FROM: Poster Session 

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant 

TP53 mutation adoption of stromal-adhesion/neuronal-like programs as a driver of stress adaptation and acute myelogenous leukemia cell survival. 

Presenter: Alexandra Thalberg, BS 

Date: Jun 1, 2026 

Abstract: 6545 

FROM: Poster Session 

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant 

A two-axis machine learning framework for cell-of-origin inference in AML: A proof-of-concept study. 

Presenter: Alexandra Thalberg, BS 

Date: Jun 1, 2026 

Abstract: 6540 

FROM: Poster Session 

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant